ReviewCancers2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets.
Nadia Ashai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it
ReviewCancers2023
Nadia Ashai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.